시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 뇌염 치료 시장 보고서(2025년)
Encephalitis Treatment Global Market Report 2025
상품코드 : 1824657
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 뇌염 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 5.7%로 확대되어 276억 6,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 건강 관리 지출 증가, 물리치료의 인기 증가, 노인 증가, 뇌염 치료 인지도 증가로 인해 발생합니다. 예측기간의 주요 동향으로는 선진적인 진단 툴, 뇌염 진단 및 치료에서의 AI 및 ML, 개별화 의약품의 개발, 예방 뇌염 백신 수요, 지지 요법 등을 들 수 있습니다.

향후 5년간의 성장률 5.7%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 오스트리아와 벨기에에서 조달하는 정맥 주사용 면역글로불린(IVIG)과 항바이러스제의 비용을 상승시키고, 급성 치료에 대한 반응을 둔화시키고, 신경과의 비용을 상승시킴으로써 미국에 지장을 초래할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

뇌염 치료 시장의 성장은 헬스케어 인프라 투자 증가로 인한 것으로 예측됩니다. 헬스케어 인프라에는 첨단 기술을 갖추고 교육을 받은 의료 전문가가 상주하는 병원, 클리닉, 의료 실험실 등 개인 및 지역사회에 대한 의료 제공을 지원하는 시설, 자원, 서비스가 포함됩니다. 효과적인 건강 관리 인프라는 전문적인 의료시설, 진단 도구 및 지원 케어에 대한 액세스를 제공함으로써 뇌염 치료에 매우 중요한 역할을 합니다. 예를 들어, 2023년 5월 미국 의료 협회는 미국 병원 수가 2021년 6,129에서 2022년 6,093으로 증가했다고 보고했습니다. 게다가 국가 통계국의 보고에 의하면, 영국의 헬스케어 지출은 2020-2021년까지 명목 9.4%, 실질 9.7% 급증했습니다. 따라서 의료 인프라 투자 증가 동향은 뇌염 치료 시장의 성장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Encephalitis treatment is the treatment of a medical condition characterized by inflammation of the brain, usually caused by a viral infection, a fungal infection, an autoimmune reaction, or certain medications. Encephalitis treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

Encephalitis can be categorized into two main types are primary encephalitis and secondary encephalitis. Primary encephalitis involves inflammation originating directly within the brain, rather than being a result of an infection originating elsewhere in the body. Treatment for primary encephalitis includes the use of antiviral medications, supportive care, and symptom management. The various treatment approaches are employed, encompassing antiviral agents, steroid injections, antibiotics, immunoglobulin therapy, plasmapheresis, and other treatments. These treatments can be administered via different routes, including oral, parenteral, and other methods. Diagnosing encephalitis involves employing various types of tests such as imaging tests, blood tests, biopsies, and other diagnostic procedures. These diagnostic tests are conducted by healthcare facilities like hospitals, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The encephalitis treatment market research report is one of a series of new reports from The Business Research Company that provides encephalitis treatment market statistics, including encephalitis treatment industry global market size, regional shares, competitors with an encephalitis treatment market share, detailed encephalitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the encephalitis treatment industry. This encephalitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The encephalitis treatment market size has grown strongly in recent years. It will grow from $21.09 billion in 2024 to $22.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to high incidence of encephalitis, prevalence of viral or bacterial infection, growing government initiatives, rising demand for preventive encephalitis vaccines.

The encephalitis treatment market size is expected to see strong growth in the next few years. It will grow to $27.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising healthcare expenditure, increase in the popularity of physical therapy, growing geriatric population, increasing awareness of encephalitis treatment. Major trends in the forecast period include advanced diagnostic tools, ai and ml in encephalitis diagnosis and treatment, development of personalized medicines, demand for preventive encephalitis vaccines, supportive cares.

The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of intravenous immunoglobulins (IVIG) and antiviral medications sourced from Austria and Belgium, thereby slowing acute treatment responses and elevating neurology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the encephalitis treatment market is expected to be driven by increased investments in healthcare infrastructure. Healthcare infrastructure encompasses facilities, resources, and services that support the delivery of medical care to individuals and communities, including hospitals, clinics, and medical laboratories equipped with advanced technology and staffed by trained healthcare professionals. Effective healthcare infrastructure plays a pivotal role in encephalitis treatment by providing access to specialized medical facilities, diagnostic tools, and supportive care. For example, in May 2023, the American Health Care Association reported that the number of hospitals in the US increased from 6,129 in 2021 to 6,093 in 2022. Additionally, healthcare spending in the UK surged by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021, according to a report by the Office for National Statistics. Therefore, the upward trend in healthcare infrastructure investment is propelling the growth of the encephalitis treatment market.

Anticipated growth in the encephalitis treatment market is attributed to the increasing incidence of neuroinvasive diseases. Neuroinvasive diseases refer to conditions where pathogens like viruses or bacteria enter the nervous system, leading to inflammation or damage to nervous tissues. The growing prevalence of neuroinvasive diseases creates a demand for encephalitis treatments, spurring investments by pharmaceutical companies and researchers in the development of new therapies and medications to address the expanding needs of patients. For example, in June 2023, the Centers for Disease Control and Prevention (CDC) reported 8 cases of neuroinvasive La Crosse virus human disease in September 2022, compared to 6 cases in July 2022. Ohio had the highest total cases reported, with 13 cases, surpassing all other regions in the USA. This underscores the driving force of an increasing number of neuroinvasive disease cases on the encephalitis treatment market's growth.

Leading companies in the encephalitis treatment market are concentrating on strategic investments to speed up the development of innovative therapies, boost their research and development efforts, and expand their clinical trial activities. For example, in September 2023, Arialys Therapeutics, a preclinical-stage company based in the US, raised $58 million in seed funding to advance its lead drug candidate, ART5803, which is aimed at treating anti-NMDA receptor encephalitis (ANRE), a common form of autoimmune encephalitis. The company plans to begin clinical trials with healthy volunteers by the end of 2024, followed by trials in ANRE patients in early 2025. Arialys is dedicated to developing targeted therapies that focus on pathogenic antibodies affecting the central nervous system.

In November 2022, Substipharm, a French pharmaceutical company, acquired the IMOJEV Japanese encephalitis vaccine from Sanofi S.A. for an undisclosed amount. This acquisition enhances Substipharm's position in the encephalitis treatment market and complements its geographic expansion efforts. Sanofi S.A. is a French pharmaceutical company known for manufacturing a wide range of medicines and vaccines, including the encephalitis vaccine.

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.

North America was the largest region in the encephalitis treatment market in 2024. The regions covered in encephalitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the encephalitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The encephalitis treatment market consists of revenues earned by entities by providing plasmapheresis, immunoglobulin therapy, computed tomography (CT scans), magnetic resonance imaging (MRI) and magnetoencephalography (MEG) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The encephalitis treatment market also includes sales of immunosuppressant drugs, antiseizure medicines and immunomodulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Encephalitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on encephalitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for encephalitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The encephalitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Encephalitis Treatment Market Characteristics

3. Encephalitis Treatment Market Trends And Strategies

4. Encephalitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Encephalitis Treatment Growth Analysis And Strategic Analysis Framework

6. Encephalitis Treatment Market Segmentation

7. Encephalitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Encephalitis Treatment Market

9. China Encephalitis Treatment Market

10. India Encephalitis Treatment Market

11. Japan Encephalitis Treatment Market

12. Australia Encephalitis Treatment Market

13. Indonesia Encephalitis Treatment Market

14. South Korea Encephalitis Treatment Market

15. Western Europe Encephalitis Treatment Market

16. UK Encephalitis Treatment Market

17. Germany Encephalitis Treatment Market

18. France Encephalitis Treatment Market

19. Italy Encephalitis Treatment Market

20. Spain Encephalitis Treatment Market

21. Eastern Europe Encephalitis Treatment Market

22. Russia Encephalitis Treatment Market

23. North America Encephalitis Treatment Market

24. USA Encephalitis Treatment Market

25. Canada Encephalitis Treatment Market

26. South America Encephalitis Treatment Market

27. Brazil Encephalitis Treatment Market

28. Middle East Encephalitis Treatment Market

29. Africa Encephalitis Treatment Market

30. Encephalitis Treatment Market Competitive Landscape And Company Profiles

31. Encephalitis Treatment Market Other Major And Innovative Companies

32. Global Encephalitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Encephalitis Treatment Market

34. Recent Developments In The Encephalitis Treatment Market

35. Encephalitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기